New CEO at UNEEG medical

Copenhagen, March 7, 2025

Martin Stenfeldt has taken over as new CEO of UNEEG medical. He succeeds Torben Sandgren, who has chosen to resign from his position after 7 years of dedicated service.

Martin Stenfeldt has previously been CEO and co-founder of MedTrace Pharma and has 20+ years of experience from the medtech industry.

Chairman of the Board Søren Westermann says; "With Martin's extensive knowledge within the medtech industry as well as his experience and success with start- and scaleup companies and funding, we are confident in handing over the reins to him."

Besides FDA clearance and early commercialization, the funding and partnering phase is the next important step for UNEEG medical, which is specializing in providing the epilepsy community with more accurate knowledge of seizures to support improvement in epilepsy care, ultimately aiming at improving patients’ quality of life.

UNEEG medical’s unique subcutaneous EEG solution for remote monitoring of brain activity achieved EC MDR approval in 2H 2024 as well as FDA ‘Break Through Device Designation’ in the USA.